News
Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster ...
More than one million people in the UK are already paying for the appetite-suppressing drug, from private clinics which ...
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results